OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism
Yajnavalka Banerjee, Anca Pantea Stoian, José Silva‐Nunes, et al.
Expert Opinion on Drug Safety (2021) Vol. 20, Iss. 11, pp. 1309-1315
Open Access | Times Cited: 23
Yajnavalka Banerjee, Anca Pantea Stoian, José Silva‐Nunes, et al.
Expert Opinion on Drug Safety (2021) Vol. 20, Iss. 11, pp. 1309-1315
Open Access | Times Cited: 23
Showing 23 citing articles:
Metformin: Sex/Gender Differences in Its Uses and Effects—Narrative Review
Ιoannis Ilias, Manfredi Rizzo, Lina Zabulienė
Medicina (2022) Vol. 58, Iss. 3, pp. 430-430
Open Access | Times Cited: 23
Ιoannis Ilias, Manfredi Rizzo, Lina Zabulienė
Medicina (2022) Vol. 58, Iss. 3, pp. 430-430
Open Access | Times Cited: 23
Noninsulin‐based antihyperglycemic medications in patients with diabetes and COVID ‐19: A systematic review and meta‐analysis
Mahmoud Nassar, Hazem Abosheaishaa, Awadhesh Kumar Singh, et al.
Journal of Diabetes (2023) Vol. 15, Iss. 2, pp. 86-96
Open Access | Times Cited: 13
Mahmoud Nassar, Hazem Abosheaishaa, Awadhesh Kumar Singh, et al.
Journal of Diabetes (2023) Vol. 15, Iss. 2, pp. 86-96
Open Access | Times Cited: 13
COVID-19 and Diabetes: Persistent Cardiovascular and Renal Risks in the Post-Pandemic Landscape
Tzu-Shan Huang, Jo-Yen Chao, Ho-Hsiang Chang, et al.
Life (2025) Vol. 15, Iss. 5, pp. 726-726
Open Access
Tzu-Shan Huang, Jo-Yen Chao, Ho-Hsiang Chang, et al.
Life (2025) Vol. 15, Iss. 5, pp. 726-726
Open Access
The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact
Nitin Kapoor, Sanjay Kalra, Wael Al Mahmeed, et al.
Diabetes Therapy (2022) Vol. 13, Iss. 10, pp. 1723-1736
Open Access | Times Cited: 18
Nitin Kapoor, Sanjay Kalra, Wael Al Mahmeed, et al.
Diabetes Therapy (2022) Vol. 13, Iss. 10, pp. 1723-1736
Open Access | Times Cited: 18
Glucometabolic Perturbations in Type 2 Diabetes Mellitus and Coronavirus Disease 2019: Causes, Consequences, and How to Counter Them Using Novel Antidiabetic Drugs – The CAPISCO International Expert Panel
Djordje S. Popovic, Νικόλαος Παπάνας, Theocharis Koufakis, et al.
Experimental and Clinical Endocrinology & Diabetes (2023) Vol. 131, Iss. 05, pp. 260-267
Closed Access | Times Cited: 8
Djordje S. Popovic, Νικόλαος Παπάνας, Theocharis Koufakis, et al.
Experimental and Clinical Endocrinology & Diabetes (2023) Vol. 131, Iss. 05, pp. 260-267
Closed Access | Times Cited: 8
Association of anti-diabetic drugs and covid-19 outcomes in patients with diabetes mellitus type 2 and chronic kidney disease: Nationwide registry analysis
Jelena Dimnjaković, Tamara Buble, Pero Ivanko, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0301056-e0301056
Open Access | Times Cited: 2
Jelena Dimnjaković, Tamara Buble, Pero Ivanko, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0301056-e0301056
Open Access | Times Cited: 2
Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review
Djordje S. Popovic, Νικόλαος Παπάνας, Anca Pantea Stoian, et al.
Diabetes Therapy (2021) Vol. 12, Iss. 12, pp. 3037-3054
Open Access | Times Cited: 15
Djordje S. Popovic, Νικόλαος Παπάνας, Anca Pantea Stoian, et al.
Diabetes Therapy (2021) Vol. 12, Iss. 12, pp. 3037-3054
Open Access | Times Cited: 15
Non-Insulin Novel Antidiabetic Drugs Mechanisms in the Pathogenesis of COVID-19
Teodor Salmen, Valeria-Anca Pietroșel, Bianca-Margareta Mihai, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2624-2624
Open Access | Times Cited: 11
Teodor Salmen, Valeria-Anca Pietroșel, Bianca-Margareta Mihai, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2624-2624
Open Access | Times Cited: 11
The role of atherogenic lipoproteins in diabetes: Molecular aspects and clinical significance
Yajnavalka Banerjee, Angelo Maria Patti, Rosaria Vincenza Giglio, et al.
Journal of Diabetes and its Complications (2023) Vol. 37, Iss. 8, pp. 108517-108517
Closed Access | Times Cited: 6
Yajnavalka Banerjee, Angelo Maria Patti, Rosaria Vincenza Giglio, et al.
Journal of Diabetes and its Complications (2023) Vol. 37, Iss. 8, pp. 108517-108517
Closed Access | Times Cited: 6
Antidiabetic Drug Efficacy in Reduction of Mortality during the COVID-19 Pandemic
Daniel Gonikman, Dmitrijs Kustovs
Medicina (2023) Vol. 59, Iss. 10, pp. 1810-1810
Open Access | Times Cited: 5
Daniel Gonikman, Dmitrijs Kustovs
Medicina (2023) Vol. 59, Iss. 10, pp. 1810-1810
Open Access | Times Cited: 5
Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 Severity
Klara R. Klein, Trine J. Abrahamsen, Anna R. Kahkoska, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 5, pp. 1169-1186
Open Access | Times Cited: 1
Klara R. Klein, Trine J. Abrahamsen, Anna R. Kahkoska, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 5, pp. 1169-1186
Open Access | Times Cited: 1
The impact of innovative glucose-lowering drugs on the course and outcome of COVID-19 in patients with type 2 diabetes mellitus
Т. Н. Маркова, M. Stas
Diabetes Mellitus (2024) Vol. 27, Iss. 2, pp. 174-184
Open Access | Times Cited: 1
Т. Н. Маркова, M. Stas
Diabetes Mellitus (2024) Vol. 27, Iss. 2, pp. 174-184
Open Access | Times Cited: 1
Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future Avenues
Ali A. Rizvi, Andrej Janež, Manfredi Rizzo
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12311-12311
Open Access | Times Cited: 8
Ali A. Rizvi, Andrej Janež, Manfredi Rizzo
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12311-12311
Open Access | Times Cited: 8
Association of COVID-19 Infection with Sociodemographic, Anthropometric and Lifestyle Factors: A Cross-Sectional Study in an Older Adults’ Population Aged over 65 Years Old
Eleni Pavlidou, Sousana Κ. Papadopoulou, Georgios Antasouras, et al.
Diseases (2023) Vol. 11, Iss. 4, pp. 165-165
Open Access | Times Cited: 3
Eleni Pavlidou, Sousana Κ. Papadopoulou, Georgios Antasouras, et al.
Diseases (2023) Vol. 11, Iss. 4, pp. 165-165
Open Access | Times Cited: 3
Absolute Hyperglycemia versus Stress Hyperglycemia Ratio for the Prognosis of Hospitalized Patients with COVID-19 in the First Months of the Pandemic: A Retrospective Study
Alexandra Abegão Matias, Inês Manique, Teresa Sabino, et al.
Diabetes Therapy (2022) Vol. 14, Iss. 2, pp. 335-346
Open Access | Times Cited: 3
Alexandra Abegão Matias, Inês Manique, Teresa Sabino, et al.
Diabetes Therapy (2022) Vol. 14, Iss. 2, pp. 335-346
Open Access | Times Cited: 3
Proposed Mechanisms and Associations of COVID-19 with Cardiometabolic Risk Factors
Koushik Reddy, Kamil F. Faridi, Monica Aggarwal, et al.
American Journal of Lifestyle Medicine (2024)
Closed Access
Koushik Reddy, Kamil F. Faridi, Monica Aggarwal, et al.
American Journal of Lifestyle Medicine (2024)
Closed Access
COVID-19 era and GLP-1 RA era: Is it a renaissance when the dusk of global tragedy co-occurring with the dawn of magical remedy?
Deepak Gupta, Berhane Seyoum, Sarwan Kumar, et al.
Medical Hypotheses (2024) Vol. 194, pp. 111516-111516
Closed Access
Deepak Gupta, Berhane Seyoum, Sarwan Kumar, et al.
Medical Hypotheses (2024) Vol. 194, pp. 111516-111516
Closed Access
Treatment of diabetes and heart failure: Facts and hopes
Manfredi Rizzo, Domenico Cianflone, Francesco Maranta
International Journal of Cardiology (2022) Vol. 359, pp. 118-119
Closed Access | Times Cited: 2
Manfredi Rizzo, Domenico Cianflone, Francesco Maranta
International Journal of Cardiology (2022) Vol. 359, pp. 118-119
Closed Access | Times Cited: 2
Molecular Endocrinology and Metabolism in 2021: What’s New
Manfredi Rizzo
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13375-13375
Open Access | Times Cited: 2
Manfredi Rizzo
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13375-13375
Open Access | Times Cited: 2
Dissecting the Interrelationship between COVID‐19 and Diabetes Mellitus
Pratiksha H. Roham, Jayesh Kamath, Shilpy Sharma
Advanced Biology (2023) Vol. 7, Iss. 8
Closed Access
Pratiksha H. Roham, Jayesh Kamath, Shilpy Sharma
Advanced Biology (2023) Vol. 7, Iss. 8
Closed Access
The Importance of a Novel Syndemic Approach for Cardiometabolic Diseases
Manfredi Rizzo
Current Medicinal Chemistry (2023) Vol. 31, Iss. 18, pp. 2483-2485
Closed Access
Manfredi Rizzo
Current Medicinal Chemistry (2023) Vol. 31, Iss. 18, pp. 2483-2485
Closed Access
Antidiabetic Drugs in COVID-19
Niki Katsiki, Maciej Banach
Contemporary cardiology (2022), pp. 351-364
Closed Access
Niki Katsiki, Maciej Banach
Contemporary cardiology (2022), pp. 351-364
Closed Access
